Saikosaponin A attenuates perimenopausal depression-like symptoms by chronic unpredictable mild stress. 2018

Xue-Qin Chen, and Shu-Jiao Chen, and Wen-Na Liang, and Miao Wang, and Cheng-Fu Li, and Shuang-Shuang Wang, and Shu-Qi Dong, and Li-Tao Yi, and Can-Dong Li
Xiamen Hospital of Traditional Chinese Medicine Affiliated to Fujian University of Traditional Chinese Medicine, Xiamen 361009, Fujian Province, PR China; Research Base of TCM Syndrome, Fujian University of Traditional Chinese Medicine, Fuzhou 350108, Fujian Province, PR China.

Accumulating studies have shown that a traditional Chinese decoction Chaihu-Shugan-San produced the antidepressant-like effects in rodents including in perimenopausal. Previous studies and our preliminary study indicated that saikosaponin A, one of the main constituents of Chaihu-Shugan-San, enhanced brain-derived neurotrophic factor (BDNF) expression in rats. Herein, this study aimed to evaluate the antidepressant-like effects of saikosaponin A in perimenopausal rats exposed to chronic unpredictable mild stress (CUMS). The sucrose preference test, novelty-suppressed feeding test and forced swimming test were performed after administration of saikosaponin A for 4 weeks. Serum corticotrophin-releasing hormone (CRH), adrenocorticotropic hormone (ACTH) and corticosterone levels, as well as hypothalamus CRH and hippocampal glucocorticoid receptor were measured. In addition, pro-inflammatory cytokines such as interleukin-1beta (IL-1β), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) in the hippocampus were detected for evaluation of the neuroinflammation. Further, BDNF levels and its receptor TrkB were also determined. Our results indicated that four-week treatment with saikosaponin A increased sucrose preference, decreased latency to feed in the novelty-suppressed feeding test and reduced the immobility time in the forced swimming test. In addition, saikosaponin A restored the dsyregulation of HPA axis and neuroinflammation in rats exposed to CUMS. Moreover, saikosaponin A promoted BDNF-TrkB signaling in the hippocampus. This study demonstrates that saikosaponin A produced the antidepressant-like effects in rats, which may be mediated by restoration of neuroendocrine, neuroinflammation and neurotrophic systems in the hippocampus during perimenopausal.

UI MeSH Term Description Entries
D009828 Oleanolic Acid A pentacyclic triterpene that occurs widely in many PLANTS as the free acid or the aglycone for many SAPONINS. It is biosynthesized from lupane. It can rearrange to the isomer, ursolic acid, or be oxidized to taraxasterol and amyrin. Oleanol,Hederins,Oleanane Triterpenes,Triterpenes, Oleanane
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents
D012503 Saponins A type of glycoside widely distributed in plants. Each consists of a sapogenin as the aglycone moiety, and a sugar. The sapogenin may be a steroid or a triterpene and the sugar may be glucose, galactose, a pentose, or a methylpentose. Saponin
D013315 Stress, Psychological Stress wherein emotional factors predominate. Cumulative Stress, Psychological,Emotional Stress,Individual Stressors,Life Stress,Psychological Cumulative Stress,Psychological Stress Experience,Psychological Stress Overload,Psychologically Stressful Conditions,Stress Experience, Psychological,Stress Measurement, Psychological,Stress Overload, Psychological,Stress Processes, Psychological,Stress, Emotional,Stressful Conditions, Psychological,Psychological Stress,Stress, Psychologic,Stressor, Psychological,Condition, Psychological Stressful,Condition, Psychologically Stressful,Conditions, Psychologically Stressful,Cumulative Stresses, Psychological,Experience, Psychological Stress,Individual Stressor,Life Stresses,Measurement, Psychological Stress,Overload, Psychological Stress,Psychologic Stress,Psychological Cumulative Stresses,Psychological Stress Experiences,Psychological Stress Measurement,Psychological Stress Measurements,Psychological Stress Overloads,Psychological Stress Processe,Psychological Stress Processes,Psychological Stresses,Psychological Stressful Condition,Psychological Stressful Conditions,Psychological Stressor,Psychological Stressors,Psychologically Stressful Condition,Stress Experiences, Psychological,Stress Processe, Psychological,Stress, Life,Stress, Psychological Cumulative,Stressful Condition, Psychological,Stressful Condition, Psychologically,Stressor, Individual
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D047648 Perimenopause The transitional period before and after MENOPAUSE. Perimenopausal symptoms are associated with irregular MENSTRUAL CYCLE and widely fluctuated hormone levels. They may appear 6 years before menopause and subside 2 to 5 years after menopause.

Related Publications

Xue-Qin Chen, and Shu-Jiao Chen, and Wen-Na Liang, and Miao Wang, and Cheng-Fu Li, and Shuang-Shuang Wang, and Shu-Qi Dong, and Li-Tao Yi, and Can-Dong Li
February 2022, Psychoneuroendocrinology,
Xue-Qin Chen, and Shu-Jiao Chen, and Wen-Na Liang, and Miao Wang, and Cheng-Fu Li, and Shuang-Shuang Wang, and Shu-Qi Dong, and Li-Tao Yi, and Can-Dong Li
November 2018, Molecular medicine reports,
Xue-Qin Chen, and Shu-Jiao Chen, and Wen-Na Liang, and Miao Wang, and Cheng-Fu Li, and Shuang-Shuang Wang, and Shu-Qi Dong, and Li-Tao Yi, and Can-Dong Li
December 2019, Metabolic brain disease,
Xue-Qin Chen, and Shu-Jiao Chen, and Wen-Na Liang, and Miao Wang, and Cheng-Fu Li, and Shuang-Shuang Wang, and Shu-Qi Dong, and Li-Tao Yi, and Can-Dong Li
March 2017, Neuroscience letters,
Xue-Qin Chen, and Shu-Jiao Chen, and Wen-Na Liang, and Miao Wang, and Cheng-Fu Li, and Shuang-Shuang Wang, and Shu-Qi Dong, and Li-Tao Yi, and Can-Dong Li
May 2017, Brain research,
Xue-Qin Chen, and Shu-Jiao Chen, and Wen-Na Liang, and Miao Wang, and Cheng-Fu Li, and Shuang-Shuang Wang, and Shu-Qi Dong, and Li-Tao Yi, and Can-Dong Li
March 2024, Behavioural brain research,
Xue-Qin Chen, and Shu-Jiao Chen, and Wen-Na Liang, and Miao Wang, and Cheng-Fu Li, and Shuang-Shuang Wang, and Shu-Qi Dong, and Li-Tao Yi, and Can-Dong Li
June 2023, Naunyn-Schmiedeberg's archives of pharmacology,
Xue-Qin Chen, and Shu-Jiao Chen, and Wen-Na Liang, and Miao Wang, and Cheng-Fu Li, and Shuang-Shuang Wang, and Shu-Qi Dong, and Li-Tao Yi, and Can-Dong Li
April 2020, Brain research bulletin,
Xue-Qin Chen, and Shu-Jiao Chen, and Wen-Na Liang, and Miao Wang, and Cheng-Fu Li, and Shuang-Shuang Wang, and Shu-Qi Dong, and Li-Tao Yi, and Can-Dong Li
February 2022, Brain and behavior,
Xue-Qin Chen, and Shu-Jiao Chen, and Wen-Na Liang, and Miao Wang, and Cheng-Fu Li, and Shuang-Shuang Wang, and Shu-Qi Dong, and Li-Tao Yi, and Can-Dong Li
November 2021, Neuroscience letters,
Copied contents to your clipboard!